.

A recent study in @NatureMedicine shows promising results for an "off-the-shelf" vaccine for patients with pancreatic & colorectal cancer that is given after surgery to prevent or delay the cancer from coming back. Read about the important advancement: bit.ly/3P4s1pv

NEW STUDY: UCLA researchers show for the first time that a gene usually linked to giant axonal neuropathy, a rare and severe neurological condition, also plays a role in inhibiting aggressive tumor cell growth in head and neck cancers. @CRC_AACR

bit.ly/3P3VxMa

UCLA-led research has resulted in FDA approval of 4-drug combination NALIRIFOX for frontline treatment of metastatic pancreatic cancer, the first study in nearly a decade to have a positive result for overall survival. bit.ly/3I8sdAm @UCLAHealth #pancreaticcancer

New study out in @NatureComms: UCLA researchers built & demonstrated the potential efficacy of a new CAR T-cell-based immunotherapy specifically designed to treat patients with cutaneous & rare subtypes of melanoma. Read about the new approach here: bit.ly/48eUPT7

The @UCLAHealth women’s cancer research team in OBGYN has played a pivotal role in a clinical trial that led to the FDA granting accelerated approval of the first antibody drug conjugate to treat platinum-resistant ovarian cancer. More: bit.ly/3SZhE8M #ovariancancer